Browse drugs

…ose receiving cyclophosphamide (CYC) and 20% of those receiving mycophenolate mofetil (MMF) achieved a renal response after 24 weeks. There were no s…

…s-matched umbilical cord blood transplant, with ciclosporin and mycophenolate mofetil as GvHD prophylaxis. Post-transplant, he developed grade 3 skin…

… brain biopsy confirmed PML. Notably, she had been treated with mycophenolate mofetil and low-dose prednisolone, without rituximab. Her symptoms impr…

…armacopoeia.Results Seven out of 13 formulations were selected: Amoxicillin 250 mg/5 mL, Amoxicillin–clavulanic acid 100 mg/mL–12.5 mg/mL, …

…everity, and management of irAEs in melanoma patients receiving ipilimumab–nivolumab therapy.Material and Methods A retrospective observat…

…rs. 100% were on tacrolimus and corticosteroids and 97% were on mycophenolate mofetil (MMF). A total of 89 PC were conducted with an average of 2.5 P…

…olone 2 mg/kg for at least 72 hours and underwent liver biopsy. Ursodeoxycholic acid was added in mixed and cholestatic drug-induced liver injury (D…

…anti-Sm, and anticardiolipin antibodies. After a flare in 2016, mycophenolate mofetil (MMF) was started, leading to remission. From 2018, she suffere…

…otic and/or immunosuppressive therapy; post-VHD treatments were aspirin (48.6%), anticoagulants (50%), hydroxychloroquine (86.1%), gluc…

…frequently azathioprine (n=10), mycophenolate mofetil (n=8), or methotrexate (n=5). RTX was administered in a median of three cycles (2–6) o…

… Due to therapeutic failure with rituximab, she was switched to anifrolumab. Twelve days after the first infusion, she developed a painful …

…d HCQ 400 mg/day. In August 2025, due to inadequate efficacy of rituximab (3 g), intolerance to MMF, and limitations on IS (due to leukop…